Hochschulschrift
Targeting the epigenetic modifier HDAC6 for cancer therapy and for overcoming drug resistance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
vi, 39 Blätter, 50 verschieden gezählte Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Literaturverzeichnis Seite 28-38
Enthält mehrere Zeitschriftenartikel, "Kumulative Dissertation"
Enthält deutsche und englische Zusammenfassung
Johannes Gutenberg-Universität Mainz, Dissertation, 2020
- Schlagwort
-
Arzneimittelresistenz
- Ereignis
-
Veröffentlichung
- (wo)
-
Mainz
- (wann)
-
Oktober 2020
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:05 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- Oktober 2020
Ähnliche Objekte (12)
Bioreductive prodrugs for the targeting of epigenetic enzymes
Epigenetic targeting of esophageal cancer
The epigenetic modifier DOT1L regulates gene regulatory networks necessary for cardiac patterning and cardiomyocyte cell cycle withdrawal
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation
Targeting reader domains of the epigenetic code
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Overcoming Observation Bias for Cancer Progression Modeling
Evaluation of the combined epigenetic targeting of LSD1 and HDAC for cell death induction in rhabdomyosarcoma cells
A mass spectrometry-based strategy for mapping modification sites for the ubiquitin-like modifier NEDD8
Nanocarrier system for overcoming multidrug resistance in cancer
Nanocarrier system for overcoming multidrug resistance in cancer
Bioreductive prodrugs for the targeting of epigenetic enzymes
Epigenetic targeting of esophageal cancer
The epigenetic modifier DOT1L regulates gene regulatory networks necessary for cardiac patterning and cardiomyocyte cell cycle withdrawal
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation
Targeting reader domains of the epigenetic code
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Overcoming Observation Bias for Cancer Progression Modeling
Evaluation of the combined epigenetic targeting of LSD1 and HDAC for cell death induction in rhabdomyosarcoma cells
A mass spectrometry-based strategy for mapping modification sites for the ubiquitin-like modifier NEDD8
Nanocarrier system for overcoming multidrug resistance in cancer
Nanocarrier system for overcoming multidrug resistance in cancer
Bioreductive prodrugs for the targeting of epigenetic enzymes
Epigenetic targeting of esophageal cancer
The epigenetic modifier DOT1L regulates gene regulatory networks necessary for cardiac patterning and cardiomyocyte cell cycle withdrawal
Lineage-specific regulation of epigenetic modifier genes in human liver and brain
The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation
Targeting reader domains of the epigenetic code
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Overcoming Observation Bias for Cancer Progression Modeling
Evaluation of the combined epigenetic targeting of LSD1 and HDAC for cell death induction in rhabdomyosarcoma cells
A mass spectrometry-based strategy for mapping modification sites for the ubiquitin-like modifier NEDD8
Nanocarrier system for overcoming multidrug resistance in cancer